The available clinical guidelines suggest that the pathogenesis of DCD involves several processes, including metabolic disorders, abnormal cerebral insulin signaling, cerebrovascular endothelial damage, neuroinflammation, and neurodegenerative changes (126). Here, INS is linked to metabolic disease.